Phase 0 Trial Evaluating the Effect of Temsirolimus on Known Pharmacodynamic Targets.

Trial Profile

Phase 0 Trial Evaluating the Effect of Temsirolimus on Known Pharmacodynamic Targets.

Completed
Phase of Trial: Phase 0

Latest Information Update: 26 Sep 2016

At a glance

  • Drugs Temsirolimus (Primary)
  • Indications Cancer
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 26 Sep 2016 Last checked against ClinicalTrials.gov record.
    • 15 Oct 2013 Planned End Date changed from 1 Aug 2014 to 1 Aug 2015 as reported by ClinicalTrials.gov.
    • 04 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top